Menu

CME Corner

Active Programs

Dialogue with the Experts: Diagnosing, Assessing, and Managing Inflammatory Rheumatic Diseases

Inflammatory rheumatic diseases, including rheumatoid arthritis (RA), psoriatic arthritis (PsA), and ankylosing spondylitis (AS), have a significant negative impact on patients’ physical functioning and quality of life. This activity will examine early recognition and guideline-driven treatment for these conditions. ...

  • Video Roundtable Video Roundtable
  • ACCME

Effective Strategies for Improving Process of Care Measures for Patients with IBD: Key Findings from a Community-Based QI Pilot

This activity will examine key findings from a quality improvement pilot designed to learn how IBD nurses in the community can proactively improve the care of patients with IBD. ...

  • Video Roundtable Video Roundtable
  • ANCC

Dialogue with the Experts: Strategies for Improving Interstitial Lung Disease Diagnosis and Treatment

An early and accurate diagnosis of ILD and its specific type is vital to directing therapy and monitoring disease course and therapeutic response, but these conditions are often mischaracterized and a correct diagnosis is very often delayed. This activity will examine recent advances in ILD diagnosis and treatment. ...

  • Video Roundtable Video Roundtable
  • ACCME

Primary Care Perspectives: Recognizing and Managing Opioid-Induced Constipation

Constipation is a common adverse effect resulting from opioid medications: an estimated 40% of patients receiving opioids to manage noncancer pain experience opioid-induced constipation (OIC). Unlike other adverse effects of opioids, such as nausea, the severity of OIC rarely diminishes over time and is often dose limiting. As a result, OIC can have a significant negative impact on activities of d ...

  • Mobile + Online on QuantiaMD Mobile + Online on QuantiaMD
  • ACCME

The Evolving Migraine Paradigm: Improving Diagnostic Accuracy

Migraine is underdiagnosed, frequently misdiagnosed, undertreated, and/or improperly managed, leading to reduced health-related quality of life, increased risk of psychiatric and medical comorbidities, and increased headache-related burden. This activity will improve clinicians' ability to diagnose migraine, resulting in improved outcomes for patients. ...

  • Mobile + Online on QuantiaMD Mobile + Online on QuantiaMD
  • ACCME

The Evolving Migraine Paradigm: Tailoring Treatment

Migraine is underdiagnosed and frequently misdiagnosed, undertreated, and/or improperly managed, leading to reduced health-related quality of life, increased risk of psychiatric and medical comorbidities, and increased headache-related burden. This activity will improve clinicians' ability to manage migraine in adult patients, resulting in improved outcomes for patients. ...

  • Mobile + Online on QuantiaMD Mobile + Online on QuantiaMD
  • ACCME

Secondary Prevention of ASCVD: Novel Therapies to Improve Outcomes in Patients with Hypercholesterolemia (AANP Program ID 17012508)

This activity will examine the current discussions surrounding statin use and the potential application of PCSK9 inhibitors. *Learners will be redirected to the AANP website. ...

  • Online Presentation Online Presentation
  • AANP

Psoriatic Arthritis: Understanding the Patient Experience to Improve Patient Satisfaction and Outcomes

The validated tools to assess PsA severity often do not capture what patients consider to be most important/challenging about their disease. To effectively engage patients when developing treatment plans, clinicians need information about the patients’ individual experiences with, perceptions of, and beliefs about PsA. In this “Rate the Quality” activity, you will meet three patients and rate the ...

  • Mobile + Online on RealCME Mobile + Online on RealCME
  • ACCME

Identifying and Managing Patients with IBD at Risk for Progressive Disease

Treatment strategies for IBD vary depending on disease type, severity, and patient risk profile. This activity will examine severity and risk assessment, guideline recommended treatment, and patient communication strategies. ...

  • Online Presentation Online Presentation
  • ACCME

Best Practices in the Use of Incretin-based Therapies in the Management of Type 2 Diabetes (AANP Program ID 16032139)

This activity will address glycemic variability and cardiovascular considerations in patients with T2DM and examine therapeutic management, with a particular focus on the optimal use of GLP-1 receptor agonists and DPP-4 inhibitors. *Learners will be redirected to the AANP website. ...

  • Online Presentation Online Presentation
  • AANP

Clinical Insights in Pediatrics: Improving Asthma Control by Optimizing Pharmacotherapy, Monitoring, and Patient Education

Millions of children and their families are affected by asthma, the most common chronic illness of childhood and the third leading cause of hospitalization among children under the age of 15. Pediatricians and pediatric nurse practitioners are uniquely positioned to care for children and adolescents with asthma, as they are heavily involved in the assessment, management, and follow-up of these pat ...

  • i-Newsletter i-Newsletter
  • ACCME
  • NAPNAP

Advances in Severe Asthma Management: The Role of Biologics for Severe Asthma

Severe asthma is a heterogeneous condition that consists of multiple phenotypes. Roughly 10% of individuals with asthma experience poor control because they suffer from an underlying severe asthma pathophysiology characterized by airway inflammation resistant to conventional therapy. This activity will examine treatments tailored to various phenotypes. ...

  • Mobile + Online on QuantiaMD Mobile + Online on QuantiaMD
  • ACCME

Advances in Severe Asthma Management: Understanding the Immunopathology of Uncontrolled Asthma

While poor asthma control is frequently attributed to poor adherence to prescribed medications and/or recommended environmental restrictions, 5% to 10% of patients experience poor control because they suffer from an underlying severe asthma pathophysiology characterized by airway inflammation resistant to conventional therapy. Severe asthma is a heterogeneous condition that consists of multiple ph ...

  • Mobile + Online on QuantiaMD Mobile + Online on QuantiaMD
  • ACCME

Motivational Interviewing to Support Shared Decision Making in MS
First Question: Should I Start Treatment?

This activity, the first in a 3-part series focused on shared decision making and patient-centered care in MS, will examine the practice of motivational interviewing (MI) and how it can help clinicians prompt patients to think about their diagnosis and therapeutic options. The management of MS is increasingly challenging due to the wide variation in the clinical course for each patient, an increas ...

  • i-Newsletter i-Newsletter
  • ACCME
  • ANCC

Shared Decision Making in Selecting Initial MS Disease-Modifying Therapy
Next Question: Which Disease-Modifying Therapy Should I Try First?

This activity, the second in a 3-part series focused on shared decision making and patient-centered care in MS, will examine the differences in MS disease-modifying therapies (DMT) and provide guidance for working together with patients to select appropriate first-line treatment. ...

  • i-Newsletter i-Newsletter
  • ACCME
  • ANCC

Shared Decision Making at the Crossroads: Adjusting MS Therapy Next Question: When Is it Time to Adjust Therapy?

This activity, the third in a 3-part series focused on shared decision making and patient-centered care in MS, will examine how to assess outcomes of DMT therapy from both patient and clinician perspectives, as well as practical strategies for working with patients to adjust therapy when necessary. ...

  • i-Newsletter i-Newsletter
  • ACCME
  • ANCC

Treatment Patterns in Family Medicine: The Role of the Primary Care Clinician in Patient-Centered Management of IBD/Module 3: Improving Adherence, Monitoring, and Communication

Inflammatory bowel disease is commonly associated with a wide range of extraintestinal manifestations that may appear in a variety of locations throughout the body. This activity, the third in a 3-part series, will review these manifestations and the primary care clinician’s role in identifying/investigating them. It will also examine patient non-adherence to medication and offer suggestions for f ...

  • i-Newsletter i-Newsletter
  • AAFP
  • AANP
  • AAPA

Treatment Patterns in Family Medicine: The Role of the Primary Care Clinician in Patient-Centered Management of IBD/Module 2: Escalating Therapy, Addressing Treatment Risks, and Co-Managing With Specialists

Patients with inflammatory bowel disease (IBD) who present with moderate to severe disease, or who relapse after treatment for mild disease will often require treatment with additional forms of therapy. Primary care clinicians are on the front line for monitoring their patients for treatment response and adverse events. This activity, the second in a 3-part series, addresses escalation of therapy ...

  • i-Newsletter i-Newsletter
  • AAFP
  • AANP
  • AAPA

Clinical Insights in Pediatrics: Diagnosing and Managing Pediatric Epilepsy

In the United States, an estimated 460,000 children have active epilepsy, and approximately 750,000 children have a history of epilepsy. Epilepsy is a complex disorder that requires careful monitoring and management. Newer pharmacologic options for the treatment of focal and generalized seizures may provide more effective treatment options in the pediatric population. In addition to managing epile ...

  • i-Newsletter i-Newsletter
  • ACCME
  • NAPNAP

Treatment Patterns in Family Medicine: The Role of the Primary Care Clinician in Patient-Centered Management of IBD/Module 1: Diagnosis and Initial Treatment Options

Inflammatory bowel disease (IBD) can be challenging to diagnose because of its heterogeneous and somewhat ambiguous clinical presentation. Despite the challenges, primary care clinicians are on the front line for assessment and initial diagnosis of these patients. Once diagnosed, even if placed under the care of a gastroenterologist, these patients will require life-long care. This activity, the f ...

  • i-Newsletter i-Newsletter
  • AAFP
  • AANP
  • AAPA

Improving the Management of Depression in Primary Care: Insights into Diagnosis and Treatment (Program ID 16052200)

Major depressive disorder (MDD) is one of the most common mental disorders diagnosed in the United States, with an estimated 16% of US adults experiencing MDD at some point during their lifetimes. According to the American Medical Association, chronic depression is often untreated and, on average, patients with depression receive the recommended quality of care only 58% of the time. The goal of th ...

  • Online Presentation Online Presentation
  • AANP

Stroke Prevention in Atrial Fibrillation: Current Evidence for Tailoring Antithrombotic Therapy (Program ID: 15111981)

Nonvalvular atrial fibrillation (AF) is the most common sustained cardiac arrhythmia encountered in clinical practice and afflicts more than 3 million people in the United States. AF is an independent risk factor for ischemic stroke severity, recurrence, and mortality. Individuals with AF have a 4 to 5 times greater risk for ischemic stroke. The National Stroke Association emphasizes the importanc ...

  • Online Presentation
  • AANP

Expired Programs

Achieving Optimal Outcomes in Patients With Inflammatory Bowel Disease

NOTE: This activity was presented as a live visiting faculty grand rounds series beginning on September 22, 2015. Participants who received credit for attending any of the live presentations are not eligible to receive credit for this online release. IBD is a chronic progressive inflammatory disorder of the GI tract, which includes Crohn’s disease (CD) and ulcerative colitis (UC). CD and UC ar ...

  • Online Presentation Online Presentation
  • ACCME

Acute Heart Failure: Current Best Practices, Ongoing Challenges, and Future Directions

Each year, more than 1 million individuals are hospitalized for heart failure (HF). Within the spectrum of HF, acute heart failure (AHF) represents a distinct challenge to clinicians. Diagnosis of AHF is often delayed because of the complex characteristics of the condition. The heterogeneous nature of AHF patients and the presence of comorbid conditions can make it difficult for clinicians to reco ...

  • Online Presentation Online Presentation
  • ACCME

Assessing Asthma Severity: A Self-Assessment and Clinical Overview

This activity is the first in a 2-part interactive series titled "Point of Care Clinical Decisions in Asthma Management." Approximately 25.7 million Americans suffer from asthma, a chronic inflammatory disorder of the airways, resulting in recurrent episodes of airflow limitation, mucus production, and cough. Despite many effective therapies and recent advances, many patients continue to experienc ...

  • Mobile + Online on RealCME Mobile + Online on RealCME
  • ACCME

Assessing Psoriatic Arthritis Severity, Setting Goals, and Monitoring Progress

Psoriatic arthritis (PsA) is a chronic inflammatory arthritis associated with psoriasis. An estimated 7.5 million Americans have psoriasis, and an estimated 30% to 40% of individuals with psoriasis also develop PsA. Symptoms of PsA include fatigue, pain and inflammation in joints, and potentially progressive joint damage. Despite the availability of a variety of treatment options, many patients wi ...

  • Online Presentation Online Presentation
  • ACCME

Diagnosis of PsA: Achieving an Accurate Assessment

Approximately 30% to 40% of people with psoriasis will also develop psoriatic arthritis (PsA), a painful and potentially disfiguring condition that remains underdiagnosed. Symptoms include fatigue, joint inflammation, and potentially progressive joint damage. This activity will examine the considerations for assessment and diagnosis of PsA. ...

  • Mobile + Online on QuantiaMD Mobile + Online on QuantiaMD
  • ACCME

IBD Diagnosis and Management: Untangling the Complexities

Inflammatory bowel disease (IBD), which comprises ulcerative colitis (UC) and Crohn’s disease (CD), is a complex condition that can be difficult to identify and treat. Carefully tailoring and monitoring care is essential because therapeutic goals and strategies differ by disease severity. New data available to clinicians are revising the management paradigm for IBD as well as the definition of dee ...

  • Mobile + Online on QuantiaMD Mobile + Online on QuantiaMD
  • ACCME

Improving Outcomes in Psoriasis: Exceeding Treatment Goals and Patient Expectations

This activity will address the management of psoriasis, including setting psoriasis treatment goals and monitoring treatment response to determine when adjustments to therapy are needed; developing tailored, evidence-based treatment regimens for individual patients; engaging patients in shared decision making for improved patient satisfaction; and considering clinical advances while developing tre ...

  • Online Presentation Online Presentation
  • ACCME

Improving Patient Satisfaction with Psoriatic Arthritis Treatment

An estimated 7.5 million Americans have psoriasis, and an estimated 30% to 40% of individuals with psoriasis also develop psoriatic arthritis (PsA). Despite the availability of a variety of treatment options, many patients with PsA continue to experience suboptimal outcomes. This activity will examine tailoring therapy to maximize patient satisfaction. ...

  • Online Presentation Online Presentation
  • ACCME

Individualizing Treatment Plans for Older Adults with T2DM

Approximately 26% of adults over age 65 in the US (11.2 million people) have diabetes. This is a heterogeneous population that includes individuals residing independently in communities, in assisted living, and in skilled nursing facilities. Management of diabetes in older adults should be carefully tailored, taking into account these variables. All members of the care team, including physicians, ...

  • i-Newsletter i-Newsletter
  • ACCME
  • ACPE
  • ANCC

Integrating Recently Approved Therapies into Psoriatic Arthritis Treatment Plans

Despite the availability of a variety of treatment options, many patients with psoriatic arthritis (PsA) continue to experience suboptimal outcomes. Recent research, however, has resulted in several newly approved and investigational agents that are likely to improve patient outcomes. This activity will examine recently approved and investigational therapies and their potential integration into tr ...

  • Online Presentation Online Presentation
  • ACCME

Management of Psoriatic Disease: Care and Ongoing Monitoring

Psoriatic arthritis (PsA) is underdiagnosed and undermanaged in the United States, and comorbidities that are often associated with PsA are sometimes overlooked. Many patients with PsA experience a significant emotional and physical impact from this condition despite an increase in options for successful treatment. This activity will examine the importance of early recognition and the consideratio ...

  • Mobile + Online on QuantiaMD Mobile + Online on QuantiaMD
  • ACCME

Opioid-Induced Constipation: Improving Outcomes With Individualized, Evidence-Based Treatment

This activity will review the safety and efficacy of available therapies to prevent and treat opioid-induced constipation. It will also examine strategies for optimizing treatment selection and adjusting therapy when necessary to help patients achieve their treatment goals and improve their overall quality of life. ...

  • Reach MD / podcast Reach MD / podcast
  • ACCME

Optimizing Asthma Control: Individualizing Therapy

This activity is the second in a 2-part interactive series titled "Point of Care Clinical Decisions in Asthma Management." Approximately 25.7 million Americans suffer from asthma, a chronic inflammatory disorder of the airways, resulting in recurrent episodes of airflow limitation, mucus production, and cough. Despite many effective therapies and recent advances, many patients continue to experien ...

  • Mobile + Online on RealCME Mobile + Online on RealCME
  • ACCME

Perspectives on the Care of Older Adults with T2DM: A Multidisciplinary Discussion

This activity features an engaging multidisciplinary faculty discussion about special considerations in the care of older adults with T2DM. Many older adults with T2DM are experiencing negative health consequences that could be prevented or improved with optimal evidence-based care. This is a heterogeneous population that includes individuals residing independently in communities, in assisted livi ...

  • Video Roundtable Video Roundtable
  • ACCME
  • ACPE
  • ANCC

Preventing Stroke in Atrial Fibrillation

Individuals with atrial fibrillation (AF) have a 4 to 5 times greater risk for ischemic stroke and tend to experience more serious strokes than those without AF. Although most strokes related to AF could be prevented with appropriate anticoagulation therapy, many patients are not receiving it. The goal of this activity is to help clinicians evaluate and optimally manage stroke risk in their patien ...

  • Mobile + Online on QuantiaMD Mobile + Online on QuantiaMD
  • ACCME

Progress Against Idiopathic Pulmonary Fibrosis

Idiopathic pulmonary fibrosis (IPF) is the most common idiopathic interstitial pneumonia, and its diagnosis and management remain a challenge in clinical practice. An expanding body of research on the pathogenesis of IPF, however, is leading to the identification of new therapeutic targets, and best practices are evolving with the emergence of new data and new therapies. This activity, which featu ...

  • Video Roundtable Video Roundtable
  • ACCME

Stroke Prevention in Atrial Fibrillation: Current Evidence for Tailoring Antithrombotic Therapy

NOTE: This activity was presented as a live visiting faculty grand rounds series beginning on August 20, 2015. Participants who received credit for attending any of the live presentations are not eligible to receive credit for this online release. Nonvalvular atrial fibrillation (AF) is the most common sustained cardiac arrhythmia encountered in clinical practice and afflicts more than 3 milli ...

  • Online Presentation Online Presentation
  • ACCME
  • ANCC

Team-Based Approaches to Enhancing Care for Older Adults With T2DM

A collaborative and engaged style of care planning generally provides the best results for patients. Physicians, NPs, PAs, pharmacists, nurses, and others who care for and support older adults with type 2 diabetes (T2DM) can be most effective working in a team, especially when managing individuals with multiple chronic problems. This activity examines the key features of a holistic, relationship-b ...

  • i-Newsletter i-Newsletter
  • ACCME
  • ACPE
  • ANCC

Treatment Patterns in Family Medicine: Clinical Perspectives on Incretin-Based Therapies in the Management of T2DM

The management of type 2 diabetes mellitus (T2DM) remains a major clinical challenge as many patients continue to struggle with achieving therapeutic goals. The goal of this activity is to improve knowledge and competency among primary care clinicians with regard to addressing glycemic variability in patients with T2DM through optimal therapeutic management, with a particular focus on the optimal ...

  • i-Newsletter i-Newsletter
  • AAFP
  • AANP
  • AAPA

Updates in the Management of COPD: Comorbidities and COPD

This activity will help clinicians achieve greater competency in the management of COPD and its myriad comorbidities. ...

  • Mobile + Online on QuantiaMD Mobile + Online on QuantiaMD
  • ACCME

Updates in the Management of COPD: Diagnosis and Management

This activity will help clinicians achieve greater competency in accurately diagnosing COPD, assessing disease severity, and optimizing the use of nonpharmacologic and pharmacologic interventions in tailored COPD treatment plans. COPD is a slowly progressive respiratory disease characterized by airflow limitation that is not fully reversible. Manifestations of COPD include dyspnea, poor exercise t ...

  • Mobile + Online on QuantiaMD Mobile + Online on QuantiaMD
  • ACCME

Updates in the Management of COPD: Managing Exacerbations

This activity will help clinicians achieve greater competency in managing exacerbations of COPD and optimizing the use of nonpharmacologic and pharmacologic interventions in tailored COPD treatment plans. ...

  • Mobile + Online on QuantiaMD Mobile + Online on QuantiaMD
  • ACCME

Using GLP-1 Receptor Agonists to Optimize Glycemic Control

The management of T2DM remains a major challenge as many patients continue to struggle with achieving glycemic control. Glucagon-like peptide 1 (GLP-1) receptor agonists, one of the newer drug classes for the treatment of T2DM, have been shown to be safe and effective in improving glycemic control. This activity will examine the use of GLP-1 receptor agonists in clinical practice, including long-t ...

  • Mobile + Online on QuantiaMD Mobile + Online on QuantiaMD
  • ACCME

Using GLP-1 Receptor Agonists to Reduce Cardiovascular Risk

The management of T2DM remains a major challenge as many patients continue to struggle with achieving therapeutic targets, including control of A1c levels, LDL cholesterol, and blood pressure. Glucagon-like peptide 1 (GLP-1) receptor agonists, one of the newer drug classes for the treatment of T2DM, may offer beneficial effects on cardiovascular risk factors. This activity will examine the use of ...

  • Mobile + Online on QuantiaMD
  • ACCME
Main Menu
EDITOR'S PICKS